Project Number 5R42AG052249-03 Agency/Funding Organization NIA Funding Year 2019 View Full Project Details for Optimization of sigma-2 receptor modulators for the treatment of cognitive dysfunction Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) a. Amyloid beta Researcher and Organization Principal Investigator IZZO, NICHOLAS JOHN Principal Investigator First Name NICHOLAS JOHN Principal Investigator Last Name IZZO Awardee Organization Cognition Therapeutics, Inc. Awardee State Pennsylvania Contact PI Country United States Project Detail Funding Opportunity Announcement PAS-17-065: Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R41/R42) FY Overall Cost $1,072,222 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official MARTIN, ZANE
